Predictors of Recurrence for High Risk Endometrial Cancer Patients

Far Eastern Memorial Hospital1 site in 1 country92 target enrollmentApril 25, 2020

ConditionsHigh-risk Endometrial Cancer

Drugsadjuvant therapy

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: High-risk Endometrial Cancer
Sponsor: Far Eastern Memorial Hospital
Enrollment: 92
Locations: 1
Primary Endpoint: Factors affecting overall survival
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.

Detailed Description

The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial cancer is high.The investigators retrospective study will analyze the factors associated with recurrence of endometrial cancer, especially for different adjuvant therapies.

Registry

clinicaltrials.gov

Start Date

April 25, 2020

End Date

November 25, 2020

Last Updated

5 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

Far Eastern Memorial Hospital

Responsible Party

Principal Investigator

Sheng-Mou Hsiao

Chief of Department of Obstetrics & Gynecology

Far Eastern Memorial Hospital

Eligibility Criteria

Inclusion Criteria

•All patients with high risk stage I endometrial cancer and all patients with stage II and stage III endometrial cancer and who underwent therapy in Far Eastern Memorial Hospital from 2009/01/01\~2019/09/17.